Drugs that contain Asenapine Maleate

1. Drug name - SAPHRIS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7741358 ALLERGAN Crystal form of asenapine maleate
Apr, 2026

(3 years from now)

US8022228 ALLERGAN Crystal form of asenapine maleate
Apr, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7741358

(Pediatric)

ALLERGAN Crystal form of asenapine maleate Oct, 2026

(4 years from now)

US8022228

(Pediatric)

ALLERGAN Crystal form of asenapine maleate Oct, 2026

(4 years from now)

Treatment: NA

Dosage: TABLET;SUBLINGUAL

More Information on Dosage
Strength Dosage Availability
EQ 2.5MG BASE TABLET;SUBLINGUAL Prescription
EQ 5MG BASE TABLET;SUBLINGUAL Prescription
EQ 10MG BASE TABLET;SUBLINGUAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.